Avoro Capital Advisors LLC Biomarin Pharmaceutical Inc Call Options Transaction History

Avoro Capital Advisors LLC

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q1 2018 May 15, 2018	SELL	$77.67 - $92.63 $10.7 Million - $12.7 Million	-137,500 Reduced 45.83%	162,500 $214,000
Q4 2017 Feb 14, 2018	BUY	$80.76 - $95.13 $24.2 Million - $28.5 Million	300,000	300,000 $135,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Avoro Capital Advisors LLC with notifications on news.